Stock Markets September 3, 2026 05:06 PM

Oura Seeks Nasdaq Listing After Rapid Revenue and Membership Gains

Health wearable maker files S-1 as revenue, membership and profitability accelerate ahead of IPO

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn

ŌURA Inc. has submitted a Form S-1 registration with the SEC for an initial public offering, applying to list on the Nasdaq Global Select Market under the ticker OURA. The San Francisco company reported sharply higher revenue, expanding profitability and a doubling of paid memberships over the last year, while financial terms for the offering remain pending.

Oura Seeks Nasdaq Listing After Rapid Revenue and Membership Gains
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • ŌURA filed an S-1 with the SEC seeking to list on the Nasdaq Global Select Market under the ticker OURA.
  • Total revenue for the nine months ended June 30, 2026 was $1.21 billion, a 74% increase year over year; hardware sales were $973.98 million and Membership revenue reached $240.53 million.
  • Paid Members doubled to 5.0 million and hardware shipments rose to 3.1 million rings in the nine-month period, supporting improved net income and Adjusted EBITDA.

ŌURA Inc., the developer of the Oura Ring and an integrated health intelligence platform, has formally filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission as it prepares for an initial public offering of its common stock. In the filing the San Francisco-based company said it had applied to list its shares on the Nasdaq Global Select Market using the symbol "OURA."

The S-1 filing arrives after a period of rapid top-line expansion and operational growth for the smart ring maker. The company did not disclose the number of shares to be offered or the proposed price range in the filing; those financial terms remain to be determined.

Major investment banks have been engaged to manage the planned offering. Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company and Jefferies are identified as joint lead book-running managers. BofA Securities, Barclays and Wells Fargo Securities are also listed as joint book-running managers, working alongside a larger syndicate of underwriters.

Key financial metrics in the filing underscore accelerating commercial momentum. For the nine months ended June 30, 2026, total revenue reached $1.21 billion, up 74% from $697.6 million in the same period a year earlier. Hardware sales were the dominant contributor to that growth, generating $973.98 million, while subscription-based Membership revenue climbed to $240.53 million, more than doubling from the prior-year period.

Profitability measures also improved year over year. Net income for the first nine months of fiscal 2026 rose to $60.77 million, compared with $1.57 million over the same period a year earlier. Adjusted EBITDA increased to $106.65 million during the nine months ended June 30, 2026.

The company said its installed base expanded markedly alongside revenue growth. Paid Members totaled 5.0 million as of June 30, 2026, versus 2.5 million a year earlier. Hardware shipments accelerated as well, with the company selling 3.1 million Oura Rings in the nine-month period compared with 1.8 million in the comparable period a year earlier.

Proceeds from the offering are slated for general corporate purposes, including technology development, working capital, operating expenses and capital expenditures. The filing also specifies that a portion of the net proceeds will be used to satisfy tax withholding and remittance obligations related to the settlement of restricted stock units.

Prior to the public filing, ŌURA completed a corporate restructuring. On March 31, 2026, the company redomiciled its parent entity from Finland to Delaware-based Oura Inc.

As the company moves toward a public listing, investors will be watching how management scales the combined hardware-and-software subscription model that underpinned recent growth. The filing provides detailed metrics on revenue mix, member growth and profitability that market participants will use to assess the company's operating leverage and capital requirements as it enters the public markets.

Risks

  • Final economic terms of the offering - including number of shares and price range - have not been set, creating uncertainty about the size and dilution impact of the IPO; this affects equity markets and investors considering allocation.
  • Execution risk remains in scaling the companys hardware-plus-subscription model as it transitions to a public company - investors will be monitoring whether membership and hardware sales growth can be sustained; this affects the wearables and health-technology sectors.
  • Market reception to the offering and the companys ability to convert its installed base into recurring revenue are uncertain, which could influence capital markets' valuation of consumer health devices and subscription models.

More from Stock Markets

Globus Medical Gains After CE Mark for Excelsius3D, Moves to Commercialize in EU and UK Sep 3, 2026 Volkswagen Unveils 'Future Plan 2030' with Deep Job Cuts, Factory and Product Overhaul Sep 3, 2026 Colombian equities climb as COLCAP hits record high; Industrials, Services and Agriculture lead gains Sep 3, 2026 DocuSign Rallies After Q2 Beat, Lifts ARR Growth Target on AI Momentum Sep 3, 2026 OpenAI Rolls Out GPT-6 Astra as Oversight Challenges Grow for Autonomous Models Sep 3, 2026